Omar Jawdat

1.5k total citations
35 papers, 232 citations indexed

About

Omar Jawdat is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Omar Jawdat has authored 35 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Omar Jawdat's work include Amyotrophic Lateral Sclerosis Research (13 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Myasthenia Gravis and Thymoma (5 papers). Omar Jawdat is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (13 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Myasthenia Gravis and Thymoma (5 papers). Omar Jawdat collaborates with scholars based in United States, Saudi Arabia and United Kingdom. Omar Jawdat's co-authors include Mazen M. Dimachkie, Richard J. Barohn, Mamatha Pasnoor, Laura Herbelin, Jeffrey Statland, April McVey, Ahmad R. Abuzinadah, Majed Dasouki, Jonathan Katz and Panying Rong and has published in prestigious journals such as Neurology, Scientific Reports and PLoS Medicine.

In The Last Decade

Omar Jawdat

29 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Jawdat United States 8 84 74 69 52 46 35 232
Mário Emílio Teixeira Dourado Júnior Brazil 11 66 0.8× 182 2.5× 38 0.6× 75 1.4× 22 0.5× 55 330
Mauricio De Castro United States 9 73 0.9× 16 0.2× 51 0.7× 18 0.3× 42 0.9× 20 230
Michele Sacchini Italy 6 70 0.8× 27 0.4× 66 1.0× 11 0.2× 53 1.2× 11 162
Marion Masingue France 7 66 0.8× 29 0.4× 53 0.8× 10 0.2× 33 0.7× 21 162
Steven B. Housley United States 7 59 0.7× 113 1.5× 110 1.6× 7 0.1× 9 0.2× 35 304
Sho Katayama Japan 7 35 0.4× 36 0.5× 44 0.6× 43 0.8× 13 0.3× 29 203
Soon-Chai Low Malaysia 6 75 0.9× 143 1.9× 301 4.4× 35 0.7× 40 0.9× 12 467
Eric Goldstein United States 9 10 0.1× 92 1.2× 31 0.4× 27 0.5× 21 0.5× 48 275
Yumi Mitsuyama Japan 8 101 1.2× 204 2.8× 54 0.8× 12 0.2× 8 0.2× 28 376
A. van der Ploeg Netherlands 5 220 2.6× 18 0.2× 55 0.8× 24 0.5× 175 3.8× 11 292

Countries citing papers authored by Omar Jawdat

Since Specialization
Citations

This map shows the geographic impact of Omar Jawdat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Jawdat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Jawdat more than expected).

Fields of papers citing papers by Omar Jawdat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Jawdat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Jawdat. The network helps show where Omar Jawdat may publish in the future.

Co-authorship network of co-authors of Omar Jawdat

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Jawdat. A scholar is included among the top collaborators of Omar Jawdat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Jawdat. Omar Jawdat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunt, Suzanne, et al.. (2024). Outcomes after intervention for enteral nutrition in patients with amyotrophic lateral sclerosis in multidisciplinary clinics. Muscle & Nerve. 70(1). 94–100. 2 indexed citations
2.
Perrin, Steven, Shafeeq Ladha, Nicholas J. Maragakis, et al.. (2024). Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial. PLoS Medicine. 21(10). e1004469–e1004469. 2 indexed citations
3.
Jawdat, Omar, Jeffrey Statland, Mamatha Pasnoor, et al.. (2024). Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study. Scientific Reports. 14(1). 21729–21729. 3 indexed citations
4.
Brown, Alexandra R., Byron J. Gajewski, Dinesh Pal Mudaranthakam, et al.. (2023). Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN. Contemporary Clinical Trials Communications. 36. 101220–101220.
5.
Farmakidis, Constantine, et al.. (2022). Non‐dystrophic myotonia: 2‐year clinical and patient reported outcomes. Muscle & Nerve. 66(2). 148–158. 4 indexed citations
6.
7.
Farmakidis, Constantine, et al.. (2021). Neuromuscular complications of Immune checkpoint inhibitors. (3003). Neurology. 96(15_supplement). 1 indexed citations
8.
Tungtur, Sudheer, Heather Wilkins, Robert S. Rogers, et al.. (2021). Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord. Scientific Reports. 11(1). 11051–11051. 8 indexed citations
9.
McVey, April, Richard J. Barohn, Jeffrey Statland, et al.. (2020). Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets. Journal of Visualized Experiments. 1 indexed citations
10.
McVey, April, Richard J. Barohn, Jeffrey Statland, et al.. (2020). Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets. Journal of Visualized Experiments. 4 indexed citations
11.
Herbelin, Laura, Mamatha Pasnoor, Omar Jawdat, et al.. (2020). Open-label Pilot Study of Ranolazine for Cramps in Amyotrophic Lateral Sclerosis (ALS). (2374). Neurology. 94(15_supplement). 1 indexed citations
12.
Pasnoor, Mamatha, Suzanne Hunt, Omar Jawdat, et al.. (2019). Retrospective longitudinal assessment of MG-ADL score with treatment of myasthenia gravis (P5.4-039). Neurology. 92(15_supplement). 1 indexed citations
13.
Ramdharry, Gita, Jasper M. Morrow, Stacie Hudgens, et al.. (2019). Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis. Muscle & Nerve. 60(2). 161–168. 8 indexed citations
14.
Barohn, Richard J., Byron J. Gajewski, Mamatha Pasnoor, et al.. (2018). Patient Assisted Intervention for Neuropathy: Comparison of treatment in real life situations (PAIN-CONTRoLS) (P1.435). Neurology. 90(15_supplement). 4 indexed citations
15.
Jawdat, Omar, et al.. (2018). Using automated electronic medical record data extraction to model ALS survival and progression. BMC Neurology. 18(1). 205–205. 11 indexed citations
16.
Dimachkie, Mazen M., Mamatha Pasnoor, Jeffrey Statland, et al.. (2017). Amyloid Myopathy as an Inclusion Body Myositis Mimic (P2.127). Neurology. 88(16_supplement). 1 indexed citations
17.
Brown, Alexandra R., Byron J. Gajewski, Lauren S. Aaronson, et al.. (2016). A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization. Trials. 17(1). 428–428. 17 indexed citations
18.
Jabari, Duaa, Mazen M. Dimachkie, Jeffrey Statland, et al.. (2015). Stiff Person Syndrome: A case series (P7.053). Neurology. 84(14_supplement).
19.
Jawdat, Omar, Jeffrey Statland, Richard J. Barohn, Jonathan Katz, & Mazen M. Dimachkie. (2015). Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis). Neurologic Clinics. 33(4). 775–785. 30 indexed citations
20.
Dimachkie, Mazen M., Mamatha Pasnoor, Richard J. Barohn, et al.. (2015). Utility of Screening for Monoclonal Gammopathy in ALS (P4.128). Neurology. 84(14_supplement).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mário Emílio Teixeira Dourado Júnior Breakdown of academic impact, for papers by Mauricio De Castro Breakdown of academic impact, for papers by Michele Sacchini Breakdown of academic impact, for papers by Marion Masingue Breakdown of academic impact, for papers by Steven B. Housley Breakdown of academic impact, for papers by Sho Katayama Breakdown of academic impact, for papers by Soon-Chai Low Breakdown of academic impact, for papers by Eric Goldstein Breakdown of academic impact, for papers by Yumi Mitsuyama Breakdown of academic impact, for papers by A. van der Ploeg
Rankless by CCL
2026